APFM Section 2 Module 3: Value Assessment
Module Description
Value assessment plays an essential role in helping payers make informed decisions about how they develop their formularies. By the end of this module, learners will be able to define the key components of a value assessment and how to compare the different types of value assessment. Participants will also learn about the different resources used for value assessment and each of their strengths and weaknesses.
Target Audience
This program is designed for mid-level managed care pharmacists and managed care professionals working in formulary management or considering a transition to formulary management.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss the role of value assessment in formulary development and management.
- Define the key components of a value assessment and how best to assess use in formulary decision-making.
- Compare and contrast the types of value assessments.
- Identify resources used for value assessments and their strengths and weaknesses.
Faculty/Authors:
Tori Dayer, PharmD
Graduate Student
University of Washington
Sean Sullivan, PhD
Professor and Dean
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
University of Washington
Advisory Board
Shawn Barger, PharmD
Lead Director, Medicare Formulary Development and Management
Password
Aimee Loucks, PharmD, BCPS
Director Clinical Pharmacy Services
Kaiser Permanente Washington
Lisa Mahan, PharmD, MS, MTM
Clinical Program Senior Manager
Cigna Healthcare
Kristen Patti, PharmD
Manager, Clinical Drug Evaluation & Policy
Blue Cross Blue Shield of Michigan
Reviewers
Steve Kheloussi, PharmD, MBA, FAMCP
Director, Professional Affairs
AMCP
Katherine Tieu, PharmD
Clinical Account Manager
Capital Rx
Drake Reiter, PharmD
Director, Pharmacy Operations
Priority Health
Financial Relationship Disclosures:
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Tori Dayer, PharmD Faculty | Research Associate, Curta Health, Consultant, Novartis Gene Therapies |
Sean Sullivan, PhD Faculty | None |
Shawn Barger, PharmD Planner | None |
Aimee Louckes, PharmD, BCPS Planner | None |
Lisa Mahan, PharmD, MS, MTM Planner | None |
Kristen Patti, PharmD Planner | IngenioRx |
Steve Kheloussi, PharmD, MBA Reviewer | None |
Drake Reiter, PharmD Reviewer | None |
Katherine Tieu, PharmD Reviewer | None |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
ACPE UAN:0233-0000-24-072-H04-P • Activity Type: Knowledge-Based
Contact Hours: 0.75
Release Date: December 13, 2024 • Expiration Date: December 13, 2027
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 0.75 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 0.75 Certificate of Completion